FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143333875> ?p ?o ?g. }

• W2143333875 endingPage "767" @default.
• W2143333875 startingPage "762" @default.
• W2143333875 abstract "Capecitabine, an anticancer prodrug, is thought to be biotransformed into active 5-fluorouracil (5-FU) by three enzymes. After oral administration, capecitabine is first metabolized to 5'-deoxy-5-fluorocytidine (5'-DFCR) by carboxylesterase (CES), then 5'-DFCR is converted to 5'-deoxy-5-fluorouridine (5'-DFUR) by cytidine deaminase. 5'-DFUR is activated to 5-FU by thymidine phosphorylase. Although high activities of drug metabolizing enzymes are expressed in human liver, the involvement of the liver in capecitabine metabolism is not fully understood. In this study, the metabolism of capecitabine in human liver was investigated in vitro. 5'-DFCR, 5'-DFUR, and 5-FU formation from capecitabine were investigated in human liver S9, microsomes, and cytosol in the presence of the inhibitor of dihydropyrimidine dehydrogenase, 5-chloro-2,4-dihydroxypyridine. 5'-DFCR, 5'-DFUR, and 5-FU were formed from capecitabine in cytosol and in the combination of microsomes and cytosol. Only 5'-DFCR formation was detected in microsomes. The apparent K(m) and V(max) values of 5-FU formation catalyzed by cytosol alone and in combination with microsomes were 8.1 mM and 106.5 pmol/min/mg protein, and 4.0 mM and 64.0 pmol/min/mg protein, respectively. The interindividual variability in 5'-DFCR formation in microsomes and cytosol among 14 human liver samples was 8.3- and 12.3-fold, respectively. Capecitabine seems to be metabolized to 5-FU in human liver. 5'-DFCR formation was exhibited in cytosol with large interindividual variability, although CES is located in microsomes in human liver. In the present study, it has been clarified that the cytosolic enzyme would be important in 5'-DFCR formation, as is CES." @default.
• W2143333875 created "2016-06-24" @default.
• W2143333875 creator A5000935001 @default.
• W2143333875 creator A5001851785 @default.
• W2143333875 creator A5029308954 @default.
• W2143333875 creator A5051993790 @default.
• W2143333875 creator A5062376392 @default.
• W2143333875 creator A5089297113 @default.
• W2143333875 creator A5015717703 @default.
• W2143333875 date "2004-06-17" @default.
• W2143333875 modified "2023-10-04" @default.
• W2143333875 title "BIOACTIVATION OF CAPECITABINE IN HUMAN LIVER: INVOLVEMENT OF THE CYTOSOLIC ENZYME ON 5′-DEOXY-5-FLUOROCYTIDINE FORMATION" @default.
• W2143333875 cites W1485550508 @default.
• W2143333875 cites W1538923111 @default.
• W2143333875 cites W1591651380 @default.
• W2143333875 cites W1775749144 @default.
• W2143333875 cites W1980850901 @default.
• W2143333875 cites W2023761031 @default.
• W2143333875 cites W2025551098 @default.
• W2143333875 cites W2026552058 @default.
• W2143333875 cites W2027228996 @default.
• W2143333875 cites W2030395635 @default.
• W2143333875 cites W2039639998 @default.
• W2143333875 cites W2043213673 @default.
• W2143333875 cites W2044970916 @default.
• W2143333875 cites W2055977724 @default.
• W2143333875 cites W2069145367 @default.
• W2143333875 cites W2090231975 @default.
• W2143333875 cites W2137194656 @default.
• W2143333875 cites W2161672948 @default.
• W2143333875 doi "https://doi.org/10.1124/dmd.32.7.762" @default.
• W2143333875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15205393" @default.
• W2143333875 hasPublicationYear "2004" @default.
• W2143333875 type Work @default.
• W2143333875 sameAs 2143333875 @default.
• W2143333875 citedByCount "51" @default.
• W2143333875 countsByYear W21433338752012 @default.
• W2143333875 countsByYear W21433338752013 @default.
• W2143333875 countsByYear W21433338752015 @default.
• W2143333875 countsByYear W21433338752016 @default.
• W2143333875 countsByYear W21433338752017 @default.
• W2143333875 countsByYear W21433338752018 @default.
• W2143333875 countsByYear W21433338752019 @default.
• W2143333875 countsByYear W21433338752020 @default.
• W2143333875 countsByYear W21433338752021 @default.
• W2143333875 countsByYear W21433338752023 @default.
• W2143333875 crossrefType "journal-article" @default.
• W2143333875 hasAuthorship W2143333875A5000935001 @default.
• W2143333875 hasAuthorship W2143333875A5001851785 @default.
• W2143333875 hasAuthorship W2143333875A5015717703 @default.
• W2143333875 hasAuthorship W2143333875A5029308954 @default.
• W2143333875 hasAuthorship W2143333875A5051993790 @default.
• W2143333875 hasAuthorship W2143333875A5062376392 @default.
• W2143333875 hasAuthorship W2143333875A5089297113 @default.
• W2143333875 hasConcept C108215921 @default.
• W2143333875 hasConcept C121608353 @default.
• W2143333875 hasConcept C123321153 @default.
• W2143333875 hasConcept C181199279 @default.
• W2143333875 hasConcept C185592680 @default.
• W2143333875 hasConcept C2776694085 @default.
• W2143333875 hasConcept C2776735402 @default.
• W2143333875 hasConcept C2777909004 @default.
• W2143333875 hasConcept C2778050828 @default.
• W2143333875 hasConcept C2779598120 @default.
• W2143333875 hasConcept C2780456651 @default.
• W2143333875 hasConcept C526805850 @default.
• W2143333875 hasConcept C54355233 @default.
• W2143333875 hasConcept C55493867 @default.
• W2143333875 hasConcept C62231903 @default.
• W2143333875 hasConcept C86803240 @default.
• W2143333875 hasConcept C87644729 @default.
• W2143333875 hasConcept C98274493 @default.
• W2143333875 hasConcept C98539663 @default.
• W2143333875 hasConceptScore W2143333875C108215921 @default.
• W2143333875 hasConceptScore W2143333875C121608353 @default.
• W2143333875 hasConceptScore W2143333875C123321153 @default.
• W2143333875 hasConceptScore W2143333875C181199279 @default.
• W2143333875 hasConceptScore W2143333875C185592680 @default.
• W2143333875 hasConceptScore W2143333875C2776694085 @default.
• W2143333875 hasConceptScore W2143333875C2776735402 @default.
• W2143333875 hasConceptScore W2143333875C2777909004 @default.
• W2143333875 hasConceptScore W2143333875C2778050828 @default.
• W2143333875 hasConceptScore W2143333875C2779598120 @default.
• W2143333875 hasConceptScore W2143333875C2780456651 @default.
• W2143333875 hasConceptScore W2143333875C526805850 @default.
• W2143333875 hasConceptScore W2143333875C54355233 @default.
• W2143333875 hasConceptScore W2143333875C55493867 @default.
• W2143333875 hasConceptScore W2143333875C62231903 @default.
• W2143333875 hasConceptScore W2143333875C86803240 @default.
• W2143333875 hasConceptScore W2143333875C87644729 @default.
• W2143333875 hasConceptScore W2143333875C98274493 @default.
• W2143333875 hasConceptScore W2143333875C98539663 @default.
• W2143333875 hasIssue "7" @default.
• W2143333875 hasLocation W21433338751 @default.
• W2143333875 hasLocation W21433338752 @default.
• W2143333875 hasOpenAccess W2143333875 @default.
• W2143333875 hasPrimaryLocation W21433338751 @default.
• W2143333875 hasRelatedWork W1977200340 @default.

• next